BBH
VanEck Vectors Biotech ETF

Up$120.06
+$1.27
(+1.07%)
As of 4:50:32 PM EDT | 11/16/18  |  Market Closed

BBH Trading Data

Open

$118.21

Low Price

$118.21

High Price

$120.29

Previous Last Price

$118.79

Bid Size

$117.73 X 800

Ask Size

$122.08 X 800

BBH Portfolio Data

AUM

$403,585,200

Shares

3,447

PE Ratio

27.79

Price / Book Ratio

4.12

Expense Ratio

0.35

Net Asset Value

$117.10

Volume

Volume

9,592

Avg. Volume (YDT)

27,062

Dollar Volume

$581,083

Weekly Avg. Volume

11,098

Monthly Avg. Volume

15,175

Quarterly Avg. Volume

13,506

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Holdings

Top 10 Holdings

Amgen Inc (AMGN)
8.6%
Gilead Sciences Inc (GILD)
7.15%
Shire Plc (SHPG)
5.7%
Biogen Inc (BIIB)
5.2%
Vertex Pharmaceuticals Inc (VRTX)
5.14%
Illumina Inc (ILMN)
5.02%
Alexion Pharmaceuticals Inc (ALXN)
5.01%
Regeneron Pharmaceuticals Inc (REGN)
4.83%
Biomarin Pharmaceutical Inc (BMRN)
4.76%
Iqvia Holdings Inc (IQV)
4.71%

Total BBH Holdings

Total Holdings: 27

Amgen Inc (AMGN)
8.6%
Gilead Sciences Inc (GILD)
7.15%
Shire Plc (SHPG)
5.7%
Biogen Inc (BIIB)
5.2%
Vertex Pharmaceuticals Inc (VRTX)
5.14%
Illumina Inc (ILMN)
5.02%
Alexion Pharmaceuticals Inc (ALXN)
5.01%
Regeneron Pharmaceuticals Inc (REGN)
4.83%
Biomarin Pharmaceutical Inc (BMRN)
4.76%
Iqvia Holdings Inc (IQV)
4.71%
Allergan Plc (AGN)
4.6%
Celgene Corp (CELG)
4.43%
Incyte Corp (INCY)
4.28%
Exact Sciences Corp (EXAS)
4.27%
Qiagen Nv (QGEN)
3.71%
Sarepta Therapeutics Inc (SRPT)
3.1%
Grifols Sa (GRFS)
3%
Charles River Laboratories Internationa (CRL)
2.93%
Neurocrine Biosciences Inc (NBIX)
2.67%
United Therapeutics Corp (UTHR)
2.3%
Nektar Therapeutics (NKTR)
2.04%
Alnylam Pharmaceuticals Inc (ALNY)
1.85%
Ionis Pharmaceuticals Inc (IONS)
1.7%
Bluebird Bio Inc (BLUE)
1.55%
Seattle Genetics Inc (SGEN)
1.42%
Market Vectors Biotech ETF (BBH)
0%
0%

BBH Technicals

Alpha

-11.74

Beta

1.18

Leverage

Long

Standard Deviation

5.71

BBH Dividends

Dividend Date

2017-12-18

Latest Dividend

0.683

Annual Dividend

0.68

Annual Dividend Rate

0.68

Annual Dividend Yield

0.58

BBH Performance

YTD Return

-3.64%

1 Year Return

-3.19%

3 Year Return

-4.71%

5 Year Return

36.67%

10 Year Return

118.87%

BBH Related Articles

Hit The Lab With These 17 Biotech ETFs

Hit The Lab With These 17 Biotech ETFs

The time to buy, regardless of sector, is usually when a particular group falls out of favor, not when it has been bid higher by scores of investors. Some investors…